Eli Lilly acquires SGX Pharmaceuticals
Eli Lilly and Company has acquired SGX Pharmaceuticals, a San Diego-based biotechnology company focused on drug discovery and development in the area of oncology.
Eli Lilly and Company resolved the previously reported government investigation into the company's US marketing and promotional practices for ``Zyprexa'', an antipsychotic drug.